Corcept Therapeutics Inc. buy Truist Financial Co.
Start price
30.09.24
/
50%
€41.88
Target price
30.09.25
€68.09
Performance (%)
47.04%
Price
15.07.25
€61.58
Summary
This prediction is currently active. With a performance of 47.04% the BUY prediction by Truist_Financial_Co_ is a big success. This prediction currently runs until 30.09.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Corcept Therapeutics Inc. | 5.990% | 5.990% |
iShares Core DAX® | -0.727% | 2.783% |
iShares Nasdaq 100 | 1.839% | 5.294% |
iShares Nikkei 225® | -2.033% | -0.196% |
iShares S&P 500 | 1.334% | 4.044% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Truist Financial Co. from $65.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€93.70
31.03.25
31.03.25
€138.36
31.03.26
31.03.26
-34.28%
15.07.25
15.07.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.62
17.06.24
17.06.24
€60.58
17.06.25
17.06.25
137.04%
18.06.25
18.06.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€30.31
04.06.24
04.06.24
€59.79
04.06.25
04.06.25
104.22%
05.06.25
05.06.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.88
02.05.24
02.05.24
€41.15
02.05.25
02.05.25
181.82%
03.05.25
03.05.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.60
16.02.24
16.02.24
€39.06
16.02.25
16.02.25
204.07%
17.02.25
17.02.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.00
06.11.23
06.11.23
€35.38
06.11.24
06.11.24
112.42%
07.11.24
07.11.24